Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
Identifieur interne : 001506 ( Istex/Corpus ); précédent : 001505; suivant : 001507Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
Auteurs : Paul Krack ; Valérie Fraix ; Alexandre Mendes ; Alim-Louis Benabid ; Pierre PollakSource :
- Movement Disorders [ 0885-3185 ] ; 2002-03.
English descriptors
Abstract
The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10163
Links to Exploration step
ISTEX:6C07AA52DDA5899615195141E82980FEA3B6AB99Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fraix, Valerie" sort="Fraix, Valerie" uniqKey="Fraix V" first="Valérie" last="Fraix">Valérie Fraix</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mendes, Alexandre" sort="Mendes, Alexandre" uniqKey="Mendes A" first="Alexandre" last="Mendes">Alexandre Mendes</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Ouis" sort="Benabid, Alim Ouis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6C07AA52DDA5899615195141E82980FEA3B6AB99</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10163</idno>
<idno type="url">https://api.istex.fr/document/6C07AA52DDA5899615195141E82980FEA3B6AB99/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001506</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001506</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Fraix, Valerie" sort="Fraix, Valerie" uniqKey="Fraix V" first="Valérie" last="Fraix">Valérie Fraix</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Mendes, Alexandre" sort="Mendes, Alexandre" uniqKey="Mendes A" first="Alexandre" last="Mendes">Alexandre Mendes</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Benabid, Alim Ouis" sort="Benabid, Alim Ouis" uniqKey="Benabid A" first="Alim-Louis" last="Benabid">Alim-Louis Benabid</name>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name>
<affiliation><mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-03">2002-03</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">S3</biblScope>
<biblScope unit="supplement">3</biblScope>
<biblScope unit="page" from="S188">S188</biblScope>
<biblScope unit="page" to="S197">S197</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6C07AA52DDA5899615195141E82980FEA3B6AB99</idno>
<idno type="DOI">10.1002/mds.10163</idno>
<idno type="ArticleID">MDS10163</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term>
<term>deep brain stimulation</term>
<term>subthalamic nucleus</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society</div>
</front>
</TEI>
<istex><corpusName>wiley</corpusName>
<author><json:item><name>Paul Krack MD</name>
<affiliations><json:string>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</json:string>
<json:string>INSERM Unit 318, Joseph Fourier University, Grenoble, France</json:string>
<json:string>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</json:string>
</affiliations>
</json:item>
<json:item><name>Valérie Fraix MD</name>
<affiliations><json:string>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</json:string>
<json:string>INSERM Unit 318, Joseph Fourier University, Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item><name>Alexandre Mendes MD</name>
<affiliations><json:string>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</json:string>
<json:string>INSERM Unit 318, Joseph Fourier University, Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item><name>Alim‐Louis Benabid MD, PhD</name>
<affiliations><json:string>INSERM Unit 318, Joseph Fourier University, Grenoble, France</json:string>
<json:string>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item><name>Pierre Pollak MD</name>
<affiliations><json:string>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</json:string>
<json:string>INSERM Unit 318, Joseph Fourier University, Grenoble, France</json:string>
</affiliations>
</json:item>
</author>
<subject><json:item><lang><json:string>eng</json:string>
</lang>
<value>subthalamic nucleus</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>deep brain stimulation</value>
</json:item>
<json:item><lang><json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
</subject>
<articleId><json:string>MDS10163</json:string>
</articleId>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>article</json:string>
</originalGenre>
<abstract>The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society</abstract>
<qualityIndicators><score>6.988</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>612 x 792 pts (letter)</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>913</abstractCharCount>
<pdfWordCount>7153</pdfWordCount>
<pdfCharCount>46412</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>124</abstractWordCount>
</qualityIndicators>
<title>Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
<refBibs><json:item><author><json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Krack</name>
</json:item>
<json:item><name>V Fraix</name>
</json:item>
</author>
<host><volume>17</volume>
<pages><last>161</last>
<first>155</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Mov Disord</title>
</host>
<title>Intraoperative micro‐ and macrostimulation of the STN in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>C Joint</name>
</json:item>
<json:item><name>D Nandi</name>
</json:item>
<json:item><name>S Parkin</name>
</json:item>
</author>
<host><volume>17</volume>
<pages><last>180</last>
<first>175</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Mov Disord</title>
</host>
<title>Hardware‐related problems of deep brain stimulation</title>
</json:item>
<json:item><author><json:item><name>J Volkmann</name>
</json:item>
<json:item><name>J Herzog</name>
</json:item>
<json:item><name>F Kopper</name>
</json:item>
<json:item><name>G Deuschl</name>
</json:item>
</author>
<host><pages><last>187</last>
<first>181</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Mov Disord</title>
</host>
<title>Introduction to the programming of deep brain stimulation</title>
</json:item>
<json:item><author><json:item><name>J Froment</name>
</json:item>
<json:item><name>H Gardère</name>
</json:item>
</author>
<host><volume>42</volume>
<pages><last>591</last>
<first>587</first>
</pages>
<author></author>
<title>Lyon Médical</title>
</host>
<title>Rigidité parkinsonienne et roue dentée: des attitudes qui les renforcent</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
</author>
<host><volume>13</volume>
<pages><last>914</last>
<first>907</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation</title>
</json:item>
<json:item><author><json:item><name>P Limousin</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
</author>
<host><volume>345</volume>
<pages><last>95</last>
<first>91</first>
</pages>
<author></author>
<title>Lancet</title>
</host>
<title>Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation</title>
</json:item>
<json:item><author><json:item><name>P Limousin</name>
</json:item>
<json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
</author>
<host><volume>339</volume>
<pages><last>1111</last>
<first>1105</first>
</pages>
<author></author>
<title>N Engl J Med</title>
</host>
<title>Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>G Deuschl</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>122</volume>
<pages><last>1146</last>
<first>1133</first>
</pages>
<author></author>
<title>Brain</title>
</host>
<title>From off‐period dystonia to peak‐dose chorea: the clinical spectrum of varying subthalamic nucleus activity</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
</author>
<host><volume>350</volume>
<pages><first>1676</first>
</pages>
<author></author>
<title>Lancet</title>
</host>
<title>Chronic stimulation of subthalamic nucleus improves levodopa‐induced dyskinesias in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>K Pfann</name>
</json:item>
<json:item><name>RD Penn</name>
</json:item>
<json:item><name>KM Shannon</name>
</json:item>
<json:item><name>DM Corcos</name>
</json:item>
</author>
<host><volume>51</volume>
<pages><last>803</last>
<first>796</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Pallidotomy and bradykinesia. Implications for basal ganglia function</title>
</json:item>
<json:item><author><json:item><name>AL Benabid</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
</author>
<host><volume>47</volume>
<pages><last>192</last>
<first>189</first>
</pages>
<issue>Suppl. 1</issue>
<author></author>
<title>Ann Neurol</title>
</host>
<title>Dyskinesias and the subthalamic nucleus</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>A Koudsie</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>13</volume>
<pages><first>296</first>
</pages>
<issue>Suppl. 2</issue>
<author></author>
<title>Mov Disord</title>
</host>
<title>The preoperative response to an acute L‐Dopa‐test predicts the outcome of subthalamic nucleus stimulation in Parkinson's disease [abstract]</title>
</json:item>
<json:item><author><json:item><name>MM Pinter</name>
</json:item>
<json:item><name>F Alesch</name>
</json:item>
<json:item><name>M Murg</name>
</json:item>
<json:item><name>RJ Helscher</name>
</json:item>
<json:item><name>H Binder</name>
</json:item>
</author>
<host><volume>246</volume>
<pages><last>913</last>
<first>907</first>
</pages>
<author></author>
<title>J Neurol</title>
</host>
<title>Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus</title>
</json:item>
<json:item><author><json:item><name>H Stolze</name>
</json:item>
<json:item><name>S Klebe</name>
</json:item>
<json:item><name>M Poepping</name>
</json:item>
</author>
<host><volume>57</volume>
<pages><last>146</last>
<first>144</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Effects of bilateral subthalamic nucleus stimulation on gait in advanced Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>JL Molinuevo</name>
</json:item>
<json:item><name>F Valldeoriola</name>
</json:item>
<json:item><name>E Tolosa</name>
</json:item>
<json:item><name>J Rumià</name>
</json:item>
</author>
<host><volume>57</volume>
<pages><last>988</last>
<first>983</first>
</pages>
<author></author>
<title>Arch Neurol</title>
</host>
<title>Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>J Volkmann</name>
</json:item>
<json:item><name>N Allert</name>
</json:item>
<json:item><name>J Voges</name>
</json:item>
<json:item><name>PH Weiss</name>
</json:item>
<json:item><name>HJ Freund</name>
</json:item>
<json:item><name>V Sturm</name>
</json:item>
</author>
<host><volume>56</volume>
<pages><last>551</last>
<first>548</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD</title>
</json:item>
<json:item><author><json:item><name>E Moro</name>
</json:item>
<json:item><name>M Scerrati</name>
</json:item>
<json:item><name>LMA Romito</name>
</json:item>
<json:item><name>R Roselli</name>
</json:item>
<json:item><name>P Tonali</name>
</json:item>
<json:item><name>A Albanese</name>
</json:item>
</author>
<host><volume>53</volume>
<pages><last>90</last>
<first>85</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
</author>
<host><volume>121</volume>
<pages><last>457</last>
<first>451</first>
</pages>
<author></author>
<title>Brain</title>
</host>
<title>Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>R Kumar</name>
</json:item>
<json:item><name>C Ardouin</name>
</json:item>
</author>
<host><volume>16</volume>
<pages><last>875</last>
<first>867</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Mirthful laughter induced by subthalamic nucleus stimulation</title>
</json:item>
<json:item><author><json:item><name>M Krause</name>
</json:item>
<json:item><name>W Fogel</name>
</json:item>
<json:item><name>A Heck</name>
</json:item>
</author>
<host><volume>70</volume>
<pages><last>470</last>
<first>464</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus</title>
</json:item>
<json:item><author><json:item><name>A Funkiewiez</name>
</json:item>
<json:item><name>C Ardouin</name>
</json:item>
<json:item><name>P Krack</name>
</json:item>
</author>
<host><volume>15</volume>
<pages><first>52</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Mov Disord</title>
</host>
<title>Acute psychic effects of bilateral subthalamic nucleus stimulation in Parkinson's disease [abstract]</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>C Ardouin</name>
</json:item>
<json:item><name>A Funkiewiez</name>
</json:item>
</author>
<host><pages><last>340</last>
<first>333</first>
</pages>
<author></author>
<title>Basal ganglia and thalamus in health and movement disorders</title>
</host>
<title>What is the influence of STN stimulation on the limbic loop?</title>
</json:item>
<json:item><author><json:item><name>P Limousin</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>D Hoffmann</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>11</volume>
<pages><last>235</last>
<first>231</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>MH Marion</name>
</json:item>
</author>
<host><volume>9</volume>
<pages><last>615</last>
<first>610</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Apraxia of lid opening a palpebral dystonia: clinical study of 32 patients</title>
</json:item>
<json:item><author><json:item><name>GR Leichnetz</name>
</json:item>
</author>
<host><volume>49</volume>
<pages><last>396</last>
<first>387</first>
</pages>
<author></author>
<title>J Neurol Sci</title>
</host>
<title>The prefrontal cortico‐oculomotor trajectories in the monkey. A possible explanation for the effects of stimulation/lesion experiments on eye movement</title>
</json:item>
<json:item><host><author></author>
<title>Leigh RJ, Zee DS. The neurology of eye movements. 3rd ed. New York, Oxford: Oxford University Press; 1999.</title>
</host>
</json:item>
<json:item><author><json:item><name>K Sano</name>
</json:item>
<json:item><name>Y Mayanagi</name>
</json:item>
<json:item><name>H Sekino</name>
</json:item>
<json:item><name>M Ogashiwa</name>
</json:item>
<json:item><name>B Ishijima</name>
</json:item>
</author>
<host><volume>33</volume>
<pages><last>707</last>
<first>689</first>
</pages>
<author></author>
<title>J Neurosurg</title>
</host>
<title>Results of stimulation and destruction of the posterior hypothalamus in man</title>
</json:item>
<json:item><author><json:item><name>A Parent</name>
</json:item>
<json:item><name>LN Hazrati</name>
</json:item>
</author>
<host><volume>20</volume>
<pages><last>154</last>
<first>128</first>
</pages>
<author></author>
<title>Brain Res Rev</title>
</host>
<title>Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry</title>
</json:item>
<json:item><author><json:item><name>A Funkiewiez</name>
</json:item>
<json:item><name>E Caputo</name>
</json:item>
<json:item><name>C Ardouin</name>
</json:item>
<json:item><name>P Krack</name>
</json:item>
<json:item><name>V Fraix</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
</author>
<host><volume>56</volume>
<pages><first>274</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Neurology</title>
</host>
<title>Behavioral and mood changes associated with bilateral stimulation of the subthalamic nucleus: a consecutive series of 98 parkinsonian patients [abstract]</title>
</json:item>
<json:item><author><json:item><name>J Kulisevsky</name>
</json:item>
<json:item><name>ML Berthier</name>
</json:item>
<json:item><name>A Gironell</name>
</json:item>
<json:item><name>B Pascual‐Sedano</name>
</json:item>
<json:item><name>J Molet</name>
</json:item>
<json:item><name>P Parés</name>
</json:item>
</author>
<host><volume>56</volume>
<pages><first>49</first>
</pages>
<issue>Suppl. 3</issue>
<author></author>
<title>Neurology</title>
</host>
<title>Secondary mania following subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease [abstract]</title>
</json:item>
<json:item><author><json:item><name>NJ Diederich</name>
</json:item>
<json:item><name>F Alesch</name>
</json:item>
<json:item><name>CG Goetz</name>
</json:item>
</author>
<host><volume>23</volume>
<pages><last>289</last>
<first>287</first>
</pages>
<author></author>
<title>Clin Neuropharmacol</title>
</host>
<title>Visual hallucinations induced by deep brain stimulation in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>G Guiot</name>
</json:item>
<json:item><name>S Brion</name>
</json:item>
</author>
<host><volume>89</volume>
<pages><last>580</last>
<first>578</first>
</pages>
<author></author>
<title>Rev Neurol</title>
</host>
<title>Traitement des mouvements anormaux par la coagulation pallidale. Technique et résultats</title>
</json:item>
<json:item><author><json:item><name>HJ Groenewegen</name>
</json:item>
<json:item><name>HW Berendse</name>
</json:item>
</author>
<host><volume>294</volume>
<pages><last>622</last>
<first>607</first>
</pages>
<author></author>
<title>J Comp Neurol</title>
</host>
<title>Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat</title>
</json:item>
<json:item><author><json:item><name>JA Saint‐Cyr</name>
</json:item>
<json:item><name>LL Trépanier</name>
</json:item>
<json:item><name>R Kumar</name>
</json:item>
<json:item><name>A Lozano</name>
</json:item>
</author>
<host><volume>123</volume>
<pages><last>2108</last>
<first>2091</first>
</pages>
<author></author>
<title>Brain</title>
</host>
<title>Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>M Hariz</name>
</json:item>
<json:item><name>F Johansson</name>
</json:item>
<json:item><name>P Shamsgovara</name>
</json:item>
<json:item><name>E Johansson</name>
</json:item>
<json:item><name>GM Hariz</name>
</json:item>
<json:item><name>M Fagerlund</name>
</json:item>
</author>
<host><volume>15</volume>
<pages><last>139</last>
<first>136</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study</title>
</json:item>
<json:item><author><json:item><name>C Ardouin</name>
</json:item>
<json:item><name>B Pillon</name>
</json:item>
<json:item><name>E Peiffer</name>
</json:item>
</author>
<host><volume>46</volume>
<pages><last>223</last>
<first>217</first>
</pages>
<author></author>
<title>Ann Neurol</title>
</host>
<title>Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions. A consecutive series of 62 patients</title>
</json:item>
<json:item><author><json:item><name>M Jahanshahi</name>
</json:item>
<json:item><name>CMA Ardouin</name>
</json:item>
<json:item><name>RG Brown</name>
</json:item>
</author>
<host><volume>123</volume>
<pages><last>1154</last>
<first>1142</first>
</pages>
<author></author>
<title>Brain</title>
</host>
<title>The impact of deep brain stimulation on executive function in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>B Pillon</name>
</json:item>
<json:item><name>C Ardouin</name>
</json:item>
<json:item><name>P Damier</name>
</json:item>
</author>
<host><volume>55</volume>
<pages><last>418</last>
<first>411</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Neuropsychological changes between “off” and “on” STN or GPi stimulation in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>EN Stenager</name>
</json:item>
<json:item><name>L Wermuth</name>
</json:item>
<json:item><name>E Stenager</name>
</json:item>
<json:item><name>J Boldsen</name>
</json:item>
</author>
<host><volume>90</volume>
<pages><last>72</last>
<first>70</first>
</pages>
<author></author>
<title>Acta Psychiatr Scand</title>
</host>
<title>Suicide in patients with Parkinson's disease. An epidemiological study</title>
</json:item>
<json:item><host><author></author>
<title>Hassler R, Mundinger F, Riechert T. Stereotaxis in Parkinson syndrome: clinical‐anatomical contributions to its pathophysiology. Berlin: Springer; 1979.</title>
</host>
</json:item>
<json:item><host><author></author>
<title>Speelman JD. Parkinson's disease and stereotaxic neurosurgery. Amsterdam: Rodopi; 1991.</title>
</host>
</json:item>
<json:item><author><json:item><name>P Vuilleumier</name>
</json:item>
<json:item><name>P Jallon</name>
</json:item>
</author>
<host><volume>154</volume>
<pages><last>317</last>
<first>305</first>
</pages>
<author></author>
<title>Rev Neurol</title>
</host>
<title>Epilepsy and psychiatric disorders: epidemiological data</title>
</json:item>
<json:item><author><json:item><name>I Jensen</name>
</json:item>
<json:item><name>JK Larsen</name>
</json:item>
</author>
<host><volume>42</volume>
<pages><last>265</last>
<first>256</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Mental aspects of temporal lobe epilepsy. Follow‐up of 74 patients after resection of a temporal lobe</title>
</json:item>
<json:item><author><json:item><name>B Guldvog</name>
</json:item>
<json:item><name>Y Loyning</name>
</json:item>
<json:item><name>E Hauglie‐Hansen</name>
</json:item>
<json:item><name>S Flood</name>
</json:item>
<json:item><name>H Bjornaes</name>
</json:item>
</author>
<host><volume>35</volume>
<pages><last>553</last>
<first>540</first>
</pages>
<author></author>
<title>Epilepsia</title>
</host>
<title>Surgical treatment for partial epilepsy among Norwegian adults</title>
</json:item>
<json:item><author><json:item><name>B Guldvog</name>
</json:item>
<json:item><name>Y Loyning</name>
</json:item>
<json:item><name>E Hauglie‐Hansen</name>
</json:item>
<json:item><name>S Flood</name>
</json:item>
<json:item><name>H Bjornaes</name>
</json:item>
</author>
<host><volume>35</volume>
<pages><last>565</last>
<first>554</first>
</pages>
<author></author>
<title>Epilepsia</title>
</host>
<title>Surgical treatment for partial epilepsy among Norwegian children and adolescents</title>
</json:item>
<json:item><author><json:item><name>PF Bladin</name>
</json:item>
</author>
<host><volume>33</volume>
<pages><last>907</last>
<first>898</first>
</pages>
<author></author>
<title>Epilepsia</title>
</host>
<title>Psychosocial difficulties and outcome after temporal lobectomy</title>
</json:item>
<json:item><author><json:item><name>M Gentil</name>
</json:item>
<json:item><name>P Garcia‐Ruiz</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>67</volume>
<pages><last>333</last>
<first>329</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism</title>
</json:item>
<json:item><author><json:item><name>M Gentil</name>
</json:item>
<json:item><name>P Garcia‐Ruiz</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>44</volume>
<pages><last>152</last>
<first>147</first>
</pages>
<author></author>
<title>Eur Neurol</title>
</host>
<title>Effect of bilateral deep‐brain stimulation on oral control of patients with parkinsonism</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>M Gentil</name>
</json:item>
<json:item><name>S Pinto</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
</author>
<host><volume>5</volume>
<pages><first>106</first>
</pages>
<author></author>
<title>Parkinsonism Relat Disord</title>
</host>
<title>Effects of subthalamic nucleus stimulation on parkinsonian speech [abstract]</title>
</json:item>
<json:item><author><json:item><name>S Brion</name>
</json:item>
<json:item><name>G Guiot</name>
</json:item>
</author>
<host><volume>110</volume>
<pages><last>144</last>
<first>123</first>
</pages>
<author></author>
<title>Rev Neurol</title>
</host>
<title>Topographie des faisceaux de projection du cortex dans la capsule interne et dans le pédoncule cérébral</title>
</json:item>
<json:item><author><json:item><name>EA Spiegel</name>
</json:item>
<json:item><name>HT Wycis</name>
</json:item>
<json:item><name>EG Szekely</name>
</json:item>
</author>
<host><volume>16</volume>
<pages><last>548</last>
<first>537</first>
</pages>
<author></author>
<title>Electroencephalogr Clin Neurophysiol</title>
</host>
<title>Stimulation of Forel's field during stereotaxic operations in the human brain</title>
</json:item>
<json:item><author><json:item><name>J Volkmann</name>
</json:item>
<json:item><name>W Fogel</name>
</json:item>
<json:item><name>P Krack</name>
</json:item>
</author>
<host><volume>27</volume>
<pages><last>39</last>
<first>23</first>
</pages>
<issue>Suppl.</issue>
<author></author>
<title>Akt Neurol</title>
</host>
<title>Postoperatives neurologisches Management bei Stimulation des Nucleus subthalamicus</title>
</json:item>
<json:item><author><json:item><name>KJ Felice</name>
</json:item>
<json:item><name>GR Keilson</name>
</json:item>
<json:item><name>J William</name>
</json:item>
</author>
<host><volume>40</volume>
<pages><last>1005</last>
<first>1004</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>“Rubral” gait ataxia</title>
</json:item>
<json:item><author><json:item><name>BP Bejjani</name>
</json:item>
<json:item><name>P Damier</name>
</json:item>
<json:item><name>I Arnulf</name>
</json:item>
</author>
<host><volume>340</volume>
<pages><last>1480</last>
<first>1476</first>
</pages>
<author></author>
<title>N Engl J Med</title>
</host>
<title>Transient acute depression induced by high‐frequency deep‐brain stimulation</title>
</json:item>
<json:item><host><author></author>
<title>Kandel EI. Functional and stereotactic neurosurgery. New York: Plenum Medical Book Company; 2001.</title>
</host>
</json:item>
<json:item><host><author></author>
<title>Hess WR. Das Zwischenhirn, Syndrome, Lokalisationen, Funktionen. Basel: Schwabe; 1954.</title>
</host>
</json:item>
<json:item><author><json:item><name>L Mihailovic</name>
</json:item>
<json:item><name>JMR Delgado</name>
</json:item>
</author>
<host><volume>19</volume>
<pages><last>36</last>
<first>21</first>
</pages>
<author></author>
<title>J Neurophysiol</title>
</host>
<title>Electrical stimulation of monkey brain with various frequencies and pulse durations</title>
</json:item>
<json:item><author><json:item><name>AL Benabid</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>C Gervason</name>
</json:item>
</author>
<host><volume>337</volume>
<pages><last>406</last>
<first>403</first>
</pages>
<author></author>
<title>Lancet</title>
</host>
<title>Long‐term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus</title>
</json:item>
<json:item><author><json:item><name>R Garcin</name>
</json:item>
<json:item><name>I Bertrand</name>
</json:item>
<json:item><name>M Kipfer</name>
</json:item>
<json:item><name>J Gruner</name>
</json:item>
<json:item><name>M Pestel</name>
</json:item>
</author>
<host><volume>81</volume>
<pages><last>968</last>
<first>964</first>
</pages>
<author></author>
<title>Rev Neurol</title>
</host>
<title>Hémiballismus. Etude anatomo‐clinique</title>
</json:item>
<json:item><author><json:item><name>R Houdart</name>
</json:item>
<json:item><name>H Mamo</name>
</json:item>
<json:item><name>M Dondey</name>
</json:item>
<json:item><name>J Cophignon</name>
</json:item>
</author>
<host><volume>112</volume>
<pages><last>529</last>
<first>521</first>
</pages>
<author></author>
<title>Rev Neurol</title>
</host>
<title>Résultat des coagulations sous‐thalamiques dans la maladie de Parkinson</title>
</json:item>
<json:item><author><json:item><name>PW Carmel</name>
</json:item>
</author>
<host><volume>18</volume>
<pages><last>387</last>
<first>378</first>
</pages>
<author></author>
<title>Arch Neurol</title>
</host>
<title>Sympathetic deficits following thalamotomy</title>
</json:item>
<json:item><author><json:item><name>YK Kim</name>
</json:item>
<json:item><name>W Umbach</name>
</json:item>
</author>
<host><volume>34</volume>
<pages><last>160</last>
<first>156</first>
</pages>
<author></author>
<title>Confin Neurol</title>
</host>
<title>The effects of stereotactic subthalamotomy on sympathetic tonus</title>
</json:item>
<json:item><author><json:item><name>R Schiffter</name>
</json:item>
<json:item><name>P Pohl</name>
</json:item>
</author>
<host><volume>216</volume>
<pages><last>392</last>
<first>379</first>
</pages>
<author></author>
<title>Arch Psychiat Nervenkr</title>
</host>
<title>Zum Verlauf der absteigenden zentralen Sympathikusbahn</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>D Hoffman</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>14</volume>
<pages><last>539</last>
<first>537</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Decrease in akinesia seems to result from chronic electrical stimulation in the external (GPe) rather than internal (GPi) pallidum [reply]</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>42</volume>
<pages><first>129</first>
</pages>
<author></author>
<title>Ann Neurol</title>
</host>
<title>Levodopa‐inhibiting effect of pallidal surgery</title>
</json:item>
<json:item><author><json:item><name>B Bejjani</name>
</json:item>
<json:item><name>P Damier</name>
</json:item>
<json:item><name>I Arnulf</name>
</json:item>
</author>
<host><volume>49</volume>
<pages><last>1569</last>
<first>1564</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Pallidal stimulation for Parkinson's disease. Two targets?</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
</author>
<host><volume>43</volume>
<pages><last>192</last>
<first>180</first>
</pages>
<author></author>
<title>Ann Neurol</title>
</host>
<title>Opposite motor effects of pallidal stimulation in Parkinson's disease</title>
</json:item>
<json:item><author><json:item><name>P Krack</name>
</json:item>
<json:item><name>P Pollak</name>
</json:item>
<json:item><name>P Limousin</name>
</json:item>
<json:item><name>D Hoffmann</name>
</json:item>
<json:item><name>A Benazzouz</name>
</json:item>
<json:item><name>AL Benabid</name>
</json:item>
</author>
<host><volume>13</volume>
<pages><last>652</last>
<first>648</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Inhibition of levodopa‐effects by internal pallidal stimulation</title>
</json:item>
</refBibs>
<genre><json:string>article</json:string>
</genre>
<host><volume>17</volume>
<publisherId><json:string>MDS</json:string>
</publisherId>
<pages><total>10</total>
<last>S197</last>
<first>S188</first>
</pages>
<issn><json:string>0885-3185</json:string>
</issn>
<issue>S3</issue>
<genre><json:string>journal</json:string>
</genre>
<language><json:string>unknown</json:string>
</language>
<eissn><json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi><json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<categories><wos><json:string>science</json:string>
<json:string>clinical neurology</json:string>
</wos>
<scienceMetrix><json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>neurology & neurosurgery</json:string>
</scienceMetrix>
</categories>
<publicationDate>2002</publicationDate>
<copyrightDate>2002</copyrightDate>
<doi><json:string>10.1002/mds.10163</json:string>
</doi>
<id>6C07AA52DDA5899615195141E82980FEA3B6AB99</id>
<score>0.20910923</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/6C07AA52DDA5899615195141E82980FEA3B6AB99/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/6C07AA52DDA5899615195141E82980FEA3B6AB99/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/6C07AA52DDA5899615195141E82980FEA3B6AB99/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<availability><p>Copyright © 2002 Movement Disorders Society</p>
</availability>
<date>2002</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
<author xml:id="author-1"><persName><forename type="first">Paul</forename>
<surname>Krack</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<affiliation>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</affiliation>
</author>
<author xml:id="author-2"><persName><forename type="first">Valérie</forename>
<surname>Fraix</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
</author>
<author xml:id="author-3"><persName><forename type="first">Alexandre</forename>
<surname>Mendes</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
</author>
<author xml:id="author-4"><persName><forename type="first">Alim‐Louis</forename>
<surname>Benabid</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
</author>
<author xml:id="author-5"><persName><forename type="first">Pierre</forename>
<surname>Pollak</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
</author>
</analytic>
<monogr><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-03"></date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue">S3</biblScope>
<biblScope unit="supplement">3</biblScope>
<biblScope unit="page" from="S188">S188</biblScope>
<biblScope unit="page" to="S197">S197</biblScope>
</imprint>
</monogr>
<idno type="istex">6C07AA52DDA5899615195141E82980FEA3B6AB99</idno>
<idno type="DOI">10.1002/mds.10163</idno>
<idno type="ArticleID">MDS10163</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>2002</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head>
<item><term>subthalamic nucleus</term>
</item>
<item><term>deep brain stimulation</term>
</item>
<item><term>Parkinson's disease</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc><change when="2002-03">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/6C07AA52DDA5899615195141E82980FEA3B6AB99/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>New York</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup><id type="product" value="MDS"></id>
</idGroup>
<titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="35"><doi origin="wiley" registered="yes">10.1002/mds.v17:3+</doi>
<titleGroup><title type="supplementTitle">Deep Brain Stimulation for Movement Disorders</title>
</titleGroup>
<numberingGroup><numbering type="journalVolume" number="17">17</numbering>
<numbering type="journalIssue">S3</numbering>
<numbering type="supplement" number="3">3</numbering>
</numberingGroup>
<coverDate startDate="2002-03">March/April 2002</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="29" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.10163</doi>
<idGroup><id type="unit" value="MDS10163"></id>
</idGroup>
<countGroup><count type="pageTotal" number="10"></count>
</countGroup>
<copyright ownership="thirdParty">Copyright © 2002 Movement Disorders Society</copyright>
<eventGroup><event type="firstOnline" date="2002-03-28"></event>
<event type="publishedOnlineFinalForm" date="2002-03-28"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-01"></event>
</eventGroup>
<numberingGroup><numbering type="pageFirst">S188</numbering>
<numbering type="pageLast">S197</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</correspondenceTo>
<linkGroup><link type="toTypesetVersion" href="file:MDS.MDS10163.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta><countGroup><count type="figureTotal" number="0"></count>
<count type="tableTotal" number="2"></count>
<count type="referenceTotal" number="68"></count>
<count type="wordTotal" number="7003"></count>
</countGroup>
<titleGroup><title type="main" xml:lang="en">Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
<title type="short" xml:lang="en">Postoperative Management of STN DBS</title>
</titleGroup>
<creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1 #af2" corresponding="yes"><personName><givenNames>Paul</givenNames>
<familyName>Krack</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails><email normalForm="pkrack@ujf-grenoble.fr">pkrack@ujf‐grenoble.fr</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Valérie</givenNames>
<familyName>Fraix</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Alexandre</givenNames>
<familyName>Mendes</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af2 #af3"><personName><givenNames>Alim‐Louis</givenNames>
<familyName>Benabid</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af1 #af2"><personName><givenNames>Pierre</givenNames>
<familyName>Pollak</familyName>
<degrees>MD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup><affiliation xml:id="af1" countryCode="FR" type="organization"><unparsedAffiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="FR" type="organization"><unparsedAffiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="FR" type="organization"><unparsedAffiliation>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">subthalamic nucleus</keyword>
<keyword xml:id="kwd2">deep brain stimulation</keyword>
<keyword xml:id="kwd3">Parkinson's disease</keyword>
</keywordGroup>
<abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title>
<p>The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en"><title>Postoperative Management of STN DBS</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en"><title>Postoperative management of subthalamic nucleus stimulation for Parkinson's disease</title>
</titleInfo>
<name type="personal"><namePart type="given">Paul</namePart>
<namePart type="family">Krack</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<affiliation>Department of Neurology, University of Grenoble, BP 217, 38043 Grenoble Cedex 09, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Valérie</namePart>
<namePart type="family">Fraix</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alexandre</namePart>
<namePart type="family">Mendes</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Alim‐Louis</namePart>
<namePart type="family">Benabid</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurochirurgie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Pierre</namePart>
<namePart type="family">Pollak</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, Grenoble, France</affiliation>
<affiliation>INSERM Unit 318, Joseph Fourier University, Grenoble, France</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place><placeTerm type="text">New York</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2002-03</dateIssued>
<copyrightDate encoding="w3cdtf">2002</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription><internetMediaType>text/html</internetMediaType>
<extent unit="tables">2</extent>
<extent unit="references">68</extent>
<extent unit="words">7003</extent>
</physicalDescription>
<abstract lang="en">The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson’ s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel decrease in antiparkinsonian medication while assessing the interactions of both treatments. Neurologists responsible for postoperative management of patients receiving STN DBS must have expert knowledge of the electroanatomy of the subthalamic area and be familiar with the medical treatment of motor and nonmotor symptoms, including the management of long‐term complications of levodopa treatment. Neurosurgeons who perform DBS need to understand the principles that guide the postoperative adaptation of treatment. This article defines guidelines for setting stimulation parameters, adapting drugs and managing adverse effects. © 2002 Movement Disorder Society</abstract>
<subject lang="en"><genre>keywords</genre>
<topic>subthalamic nucleus</topic>
<topic>deep brain stimulation</topic>
<topic>Parkinson's disease</topic>
</subject>
<relatedItem type="host"><titleInfo><title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated"><title>Mov. Disord.</title>
</titleInfo>
<genre type="journal">journal</genre>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part><date>2002</date>
<detail type="volume"><caption>vol.</caption>
<number>17</number>
</detail>
<detail type="issue"><caption>no.</caption>
<number>S3</number>
</detail>
<detail type="supplement"><caption>Suppl. no.</caption>
<number>3</number>
</detail>
<extent unit="pages"><start>S188</start>
<end>S197</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">6C07AA52DDA5899615195141E82980FEA3B6AB99</identifier>
<identifier type="DOI">10.1002/mds.10163</identifier>
<identifier type="ArticleID">MDS10163</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2002 Movement Disorders Society</accessCondition>
<recordInfo><recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001506 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001506 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:6C07AA52DDA5899615195141E82980FEA3B6AB99 |texte= Postoperative management of subthalamic nucleus stimulation for Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |